1. Home
  2. YMAT vs LEXX Comparison

YMAT vs LEXX Comparison

Compare YMAT & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo J-Star Holding Co. Ltd. Ordinary Shares

YMAT

J-Star Holding Co. Ltd. Ordinary Shares

HOLD

Current Price

$1.82

Market Cap

7.3M

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$11.00

Market Cap

8.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YMAT
LEXX
Founded
1970
2004
Country
Taiwan
Canada
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3M
8.7M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
YMAT
LEXX
Price
$1.82
$11.00
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
32.6K
92.8K
Earning Date
05-13-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$705,923.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$601.47
P/E Ratio
$10.92
N/A
Revenue Growth
N/A
52.05
52 Week Low
$0.24
$0.35
52 Week High
$2.94
$12.89

Technical Indicators

Market Signals
Indicator
YMAT
LEXX
Relative Strength Index (RSI) N/A 83.12
Support Level N/A $0.65
Resistance Level N/A N/A
Average True Range (ATR) 0.00 1.01
MACD 0.00 0.40
Stochastic Oscillator 0.00 69.36

Price Performance

Historical Comparison
YMAT
LEXX

About YMAT J-Star Holding Co. Ltd. Ordinary Shares

J-Star Holding Co Ltd is engaged in the research, development, and manufacturing of carbon fiber for a wide variety-of-products including carbon bicycles, carbon rackets, automotive parts, outdoor sports gears, and healthcare products. The company has five segments: Bicycle frame, Racket, Crank, Service provision, and Others. The majority of its revenue is generated from the Bicycle frame segment. Geographically, the company operates in Taiwan, China, and other regions.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: